Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Nigel Crockett Insider Profile
4 Followers
Nigel Crockett, CBO at Bicycle Therapeutics, holds 45.82K shares in Bicycle Therapeutics (Ticker: BCYC). Most recently, Nigel Crockett Sold $972 shares of Bicycle Therapeutics on Oct 04, 2024 for an estimated value of 21.64K.
Profitable Transactions
6 out of 8 Profitable Transactions
Average Return
+20.40%
Average return per transaction
Time Frame
Compare to
Insider Roles
CBO
Roles that Nigel Crockett holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Sell
Date:Jan 05, 2023 - Jan 05, 2024
Return:+45.20%
The most profitable trade made by Nigel Crockett
Nigel Crockett's Trading History
List of latest transactions for each holding click on a transaction to see Nigel Crockett's performance on stock
You May Also Like
Nigel Crockett insider profile FAQ
What is the percentage of profitable transactions made by Nigel Crockett?
The percentage of profitable transactions made by Nigel Crockett is 75%.
What is the average return per transaction made by Nigel Crockett?
The average return per transaction made by Nigel Crockett is 20.40%.
What stocks does Nigel Crockett hold?
Nigel Crockett holds: BCYC stocks.
What was Nigel Crockett’s latest transaction?
Nigel Crockett latest transaction was an Informative Sell of $21.64K.
What was Nigel Crockett's most profitable transaction?
Nigel Crockett’s most profitable transaction was an Informative Sell of BCYC stock on January 5, 2023. The return on the trade was 45.20%.
What is Nigel Crockett's role in Bicycle Therapeutics?
Nigel Crockett's role in Bicycle Therapeutics is CBO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.